These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7876563

  • 1. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.
    Nelson DM, Butters KA, Markert ML, Reinsmoen NL, McIvor RS.
    J Immunol; 1995 Mar 15; 154(6):3006-14. PubMed ID: 7876563
    [Abstract] [Full Text] [Related]

  • 2. Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency.
    Foresman MD, Nelson DM, McIvor RS.
    Hum Gene Ther; 1992 Dec 15; 3(6):625-31. PubMed ID: 1482702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro.
    Toro A, Paiva M, Ackerley C, Grunebaum E.
    Cell Immunol; 2006 Apr 15; 240(2):107-15. PubMed ID: 16930574
    [Abstract] [Full Text] [Related]

  • 6. Purine nucleoside phosphorylase deficiency.
    Markert ML.
    Immunodefic Rev; 1991 Apr 15; 3(1):45-81. PubMed ID: 1931007
    [Abstract] [Full Text] [Related]

  • 7. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
    Gadi VK, Alexander SD, Kudlow JE, Allan P, Parker WB, Sorscher EJ.
    Gene Ther; 2000 Oct 15; 7(20):1738-43. PubMed ID: 11083495
    [Abstract] [Full Text] [Related]

  • 8. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
    Hughes BW, Wells AH, Bebok Z, Gadi VK, Garver RI, Parker WB, Sorscher EJ.
    Cancer Res; 1995 Aug 01; 55(15):3339-45. PubMed ID: 7614469
    [Abstract] [Full Text] [Related]

  • 9. [Purine nucleoside phosphorylase activity in T-enriched preparations of human peripheral lymphocytes].
    Russo M, Pizzella T, Nardiello S, Galanti B.
    Boll Soc Ital Biol Sper; 1981 May 15; 57(9):990-2. PubMed ID: 6793048
    [Abstract] [Full Text] [Related]

  • 10. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.
    Hagani AB, Rivière I, Tan C, Krause A, Sadelain M.
    J Gene Med; 1999 May 15; 1(5):341-51. PubMed ID: 10738551
    [Abstract] [Full Text] [Related]

  • 11. Long-term expression of gene introduction into normal human T-lymphocytes by retroviral-mediated gene transfer.
    Fauser AA.
    J Cell Biochem; 1991 Apr 15; 45(4):353-8. PubMed ID: 2045429
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB, Allan PW, Hassan AE, Secrist JA, Sorscher EJ, Waud WR.
    Cancer Gene Ther; 2003 Jan 15; 10(1):23-9. PubMed ID: 12489025
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M, Casciari C, Ciurnelli R, Fulvi A, Bagnis C, Lucheroni F, Falzetti F, Mannoni P, Martelli MF, Tabilio A.
    Haematologica; 1996 Jan 15; 81(5):410-7. PubMed ID: 8952153
    [Abstract] [Full Text] [Related]

  • 15. Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes--a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies.
    Bantia S, Parker C, Upshaw R, Cunningham A, Kotian P, Kilpatrick JM, Morris P, Chand P, Babu YS.
    Int Immunopharmacol; 2010 Jul 15; 10(7):784-90. PubMed ID: 20399911
    [Abstract] [Full Text] [Related]

  • 16. Purine nucleoside phosphorylase inhibitors in T-cell malignancies.
    Bantia S, Kilpatrick JM.
    Curr Opin Drug Discov Devel; 2004 Mar 15; 7(2):243-7. PubMed ID: 15603259
    [Abstract] [Full Text] [Related]

  • 17. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.
    Otsu M, Anderson SM, Bodine DM, Puck JM, O'Shea JJ, Candotti F.
    Mol Ther; 2000 Feb 15; 1(2):145-53. PubMed ID: 10933924
    [Abstract] [Full Text] [Related]

  • 18. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.
    Huang MM, Wong A, Yu X, Kakkis E, Kohn DB.
    Gene Ther; 1997 Nov 15; 4(11):1150-9. PubMed ID: 9425437
    [Abstract] [Full Text] [Related]

  • 19. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W, Schweins E, Chen X, Finn OJ, Cheever MA.
    J Immunol; 1994 Oct 15; 153(8):3630-8. PubMed ID: 7930583
    [Abstract] [Full Text] [Related]

  • 20. EdU incorporation is an alternative non-radioactive assay to [(3)H]thymidine uptake for in vitro measurement of mice T-cell proliferations.
    Yu Y, Arora A, Min W, Roifman CM, Grunebaum E.
    J Immunol Methods; 2009 Oct 31; 350(1-2):29-35. PubMed ID: 19647746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.